- Last traded
- 17 Apr 2026
- Last close
- 43.10p
- Market cap at last close
- £151m
| 16 Apr 2026 | 16:31:53 | Holding(s) in Company |
| 16 Apr 2026 | 15:16:28 | Court Sanction of Scheme of Arrangement |
| 16 Apr 2026 | 11:52:52 | Holding(s) in Company |
| 1 Apr 2026 | 16:55:27 | Holding(s) in Company |
| 31 Mar 2026 | 13:19:42 | Holding(s) in Company |
| 29 Apr 2025 | Annual Financial Report for the year ended 31 December 2024 | |
| 10 Apr 2024 | Annual Financial Report for the Year Ended 31 December 2023 | |
| 10 Jul 2023 | Annual Financial Report for the Year Ended 31 December 2022 |
Life Science Reit plc invests in a diversified portfolio of properties in the United Kingdom, specifically targeting the life sciences sector. Its investment objective focuses on capital growth while providing a stable income stream through rental income from properties leased to tenants involved in research, development, and manufacturing activities. The trust operates within the UK commercial property sector.
| 16 Apr 2026 | 16:31:53 | Holding(s) in Company |
| 16 Apr 2026 | 15:16:28 | Court Sanction of Scheme of Arrangement |
| 16 Apr 2026 | 11:52:52 | Holding(s) in Company |
| 1 Apr 2026 | 16:55:27 | Holding(s) in Company |
| 31 Mar 2026 | 13:19:42 | Holding(s) in Company |
| 29 Apr 2025 | Annual Financial Report for the year ended 31 December 2024 | |
| 10 Apr 2024 | Annual Financial Report for the Year Ended 31 December 2023 | |
| 10 Jul 2023 | Annual Financial Report for the Year Ended 31 December 2022 |
Life Science Reit plc invests in a diversified portfolio of properties in the United Kingdom, specifically targeting the life sciences sector. Its investment objective focuses on capital growth while providing a stable income stream through rental income from properties leased to tenants involved in research, development, and manufacturing activities. The trust operates within the UK commercial property sector.
